120 related articles for article (PubMed ID: 24211383)
1. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
2. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
3. Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
Moore S; Khalaj AJ; Patel R; Yoon J; Ichwan D; Hayardeny L; Tiwari-Woodruff SK
J Neurosci Res; 2014 Dec; 92(12):1621-36. PubMed ID: 24989965
[TBL] [Abstract][Full Text] [Related]
4. Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis.
Fani Maleki A; Cisbani G; Laflamme N; Prefontaine P; Plante MM; Baillargeon J; Rangachari M; Gosselin J; Rivest S
Neurotherapeutics; 2021 Apr; 18(2):889-904. PubMed ID: 33479802
[TBL] [Abstract][Full Text] [Related]
5. Copper-zinc superoxide dismutase-deficient mice show increased susceptibility to experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein 35-55.
Massilamany C; Gangaplara A; Kim H; Stanford C; Rathnaiah G; Steffen D; Lee J; Reddy J
J Neuroimmunol; 2013 Mar; 256(1-2):19-27. PubMed ID: 23294897
[TBL] [Abstract][Full Text] [Related]
6. Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis.
Borjini N; Fernández M; Giardino L; Calzà L
J Neuroinflammation; 2016 Nov; 13(1):291. PubMed ID: 27846891
[TBL] [Abstract][Full Text] [Related]
7. Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR-124 and miR-155 in Experimental Autoimmune Encephalomyelitis.
Zha Z; Gao YF; Ji J; Sun YQ; Li JL; Qi F; Zhang N; Jin LY; Xue B; Yang T; Fan YP; Zhao H; Wang L
Oxid Med Cell Longev; 2021; 2021():5521503. PubMed ID: 33815654
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil Alleviates Murine Experimental Autoimmune Encephalomyelitis by Triggering Autophagy in the Spinal Cord.
Duarte-Silva E; Meiry da Rocha Araújo S; Oliveira WH; Lós DB; Bonfanti AP; Peron G; de Lima Thomaz L; Verinaud L; Peixoto CA
Front Immunol; 2021; 12():671511. PubMed ID: 34054847
[TBL] [Abstract][Full Text] [Related]
9. Brain inflammation in experimental autoimmune encephalomyelitis induced in Dark Agouti rats with spinal cord homogenate.
Stegnjaić G; Jevtić B; Lazarević M; Ignjatović Đ; Tomić M; Nikolovski N; Bjelobaba I; Momčilović M; Dimitrijević M; Miljković Đ; Stanisavljević S
Immunol Lett; 2024 Jun; 267():106852. PubMed ID: 38508497
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.
Kozela E; Lev N; Kaushansky N; Eilam R; Rimmerman N; Levy R; Ben-Nun A; Juknat A; Vogel Z
Br J Pharmacol; 2011 Aug; 163(7):1507-19. PubMed ID: 21449980
[TBL] [Abstract][Full Text] [Related]
11. LRRC4 functions as a neuron-protective role in experimental autoimmune encephalomyelitis.
Zhang Y; Li D; Zeng Q; Feng J; Fu H; Luo Z; Xiao B; Yang H; Wu M
Mol Med; 2021 May; 27(1):44. PubMed ID: 33932995
[TBL] [Abstract][Full Text] [Related]
12. Ginger extracts influence the expression of IL-27 and IL-33 in the central nervous system in experimental autoimmune encephalomyelitis and ameliorates the clinical symptoms of disease.
Jafarzadeh A; Mohammadi-Kordkhayli M; Ahangar-Parvin R; Azizi V; Khoramdel-Azad H; Shamsizadeh A; Ayoobi A; Nemati M; Hassan ZM; Moazeni SM; Khaksari M
J Neuroimmunol; 2014 Nov; 276(1-2):80-8. PubMed ID: 25175065
[TBL] [Abstract][Full Text] [Related]
13. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase.
Hao W; Luo Q; Menger MD; Fassbender K; Liu Y
Front Immunol; 2021; 12():792465. PubMed ID: 34975892
[TBL] [Abstract][Full Text] [Related]
14. Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis.
Ucciferri CC; Gower A; Alvarez-Sanchez N; Whetstone H; Ramaglia V; Gommerman JL; Brand-Arzamendi K; Schneider R; Dunn SE
J Vis Exp; 2024 Feb; (204):. PubMed ID: 38465945
[TBL] [Abstract][Full Text] [Related]
15. Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.
Pol S; Schweser F; Bertolino N; Preda M; Sveinsson M; Sudyn M; Babek N; Zivadinov R
Exp Neurol; 2019 Apr; 314():82-90. PubMed ID: 30684521
[TBL] [Abstract][Full Text] [Related]
16. Inflammation in an Animal Model of Multiple Sclerosis Leads to MicroRNA-25-3p Dysregulation Associated with Inhibition of Pten and Klf4.
Zare-Chahoki A; Ahmadi-Zeidabadi M; Azadarmaki S; Ghorbani S; Noorbakhsh F
Iran J Allergy Asthma Immunol; 2021 Jun; 20(3):314-325. PubMed ID: 34134453
[TBL] [Abstract][Full Text] [Related]
17. CKD-506: A novel HDAC6-selective inhibitor that exerts therapeutic effects in a rodent model of multiple sclerosis.
Bae D; Lee JY; Ha N; Park J; Baek J; Suh D; Lim HS; Ko SM; Kim T; Som Jeong D; Son WC
Sci Rep; 2021 Jul; 11(1):14466. PubMed ID: 34262061
[TBL] [Abstract][Full Text] [Related]
18. The Mixed-Lineage Kinase Inhibitor URMC-099 Protects Hippocampal Synapses in Experimental Autoimmune Encephalomyelitis.
Bellizzi MJ; Hammond JW; Li H; Gantz Marker MA; Marker DF; Freeman RS; Gelbard HA
eNeuro; 2018; 5(6):. PubMed ID: 30627663
[TBL] [Abstract][Full Text] [Related]
19. The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis.
Xie L; Chen J; McMickle A; Awar N; Nady S; Sredni B; Drew PD; Yu S
J Neuroimmunol; 2014 Aug; 273(1-2):31-41. PubMed ID: 24975323
[TBL] [Abstract][Full Text] [Related]
20. Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis.
Hassen GW; Feliberti J; Kesner L; Stracher A; Mokhtarian F
Brain Res; 2008 Oct; 1236():206-15. PubMed ID: 18725211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
